HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$4.04
Day range
$3.80 - $4.05
Year range
$1.52 - $5.54
Market cap
229.10M USD
Avg Volume
527.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.51M | 83.16% |
Net income | 76.97M | 877.01% |
Net profit margin | — | — |
Earnings per share | -0.32 | 8.57% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.19M | 31.17% |
Total assets | 114.58M | 19.26% |
Total liabilities | 38.52M | 713.65% |
Total equity | 76.06M | — |
Shares outstanding | 59.74M | — |
Price to book | 2.18 | — |
Return on assets | -43.63% | — |
Return on capital | -149.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 76.97M | 877.01% |
Cash from operations | -11.77M | 3.93% |
Cash from investing | -12.80M | 48.85% |
Cash from financing | 5.28M | — |
Net change in cash | -19.29M | 48.26% |
Free cash flow | -4.12M | 50.49% |
About
Founded
2004
Headquarters
Website
Employees
20
